Apple wins Masimo appeal, advances M5 chip as funds cut 2.7%-10.1% stakes
Apple won Masimo’s patent appeal, fast-tracked its M5 chip and edge AI rollout, and advanced foldable iPhone development while boosting smartphone shipments in China. Meanwhile, Red Door, Tritonpoint, Trust Co. of Toledo and Relyea Zuckerberg trimmed 56,228 shares, cutting positions by 2.7% to 10.1% in recent 13F filings.
1. Legal Victory Over Masimo
A federal appeals panel dismissed Masimo’s appeal seeking to invalidate key Apple sensor patents, ensuring continued production and sales of heart rate monitoring features in Apple Watch and other devices.
2. M5 Chip and Foldable iPhone Development
Apple has ramped up development of its in-house M5 chip, which will support advanced edge AI tasks like image processing and neural network inference on-device. The company is also exploring foldable iPhone form factors with flexible display prototypes in testing.
3. Institutional Stake Reductions
In recent 13F filings, four asset managers—Red Door Wealth, Tritonpoint Wealth, Trust Co. of Toledo and Relyea Zuckerberg—offloaded a total of 56,228 shares of Apple, reducing their stakes by between 2.7% and 10.1%, signaling cautious sentiment among some institutional investors.